Insider · CIK 0001472795
Alan Lotvin
Files at PROK (PROKIDNEY CORP.). First filing -, latest -.
Alan Lotvin files SEC Form 4 as director at PROK (PROKIDNEY CORP.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alan Lotvin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | PROK PROKIDNEY CORP. | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
Questions about Alan Lotvin
Answered from the filings on this page, as of the latest one.
Is Alan Lotvin buying or selling?
Alan Lotvin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alan Lotvin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan Lotvin has 0.
Where does Alan Lotvin file Form 4?
Alan Lotvin has filed Form 4 at PROK (PROKIDNEY CORP.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.